Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Organic Chemistry >Phosphines >Sodium risedronate

Sodium risedronate

Sodium risedronate Structure
  • ₹13726.1
  • Product name: Sodium risedronate
  • CAS: 115436-72-1
  • MF: C7H12NNaO7P2
  • MW: 307.11
  • EINECS:1806241-263-5
  • MDL Number:MFCD01706268
  • Synonyms:RISEDREMATE SODIUM;RISEDRONATE NA;RISEDRONATE SODIUM;RISEDRONIC ACID, SODIUM SALT;SODIUM RISEDRONATE;[1-hydroxy-2-(3-pyridinyl)ethylidene]-bis[phosphonic acid] monosodium salt;(1-hydroxy-2-(3-pyridinyl)ethylidene)bis-phosphonicacimonosodiumsalt ;risedronate,RID
1 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 50MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML0650
  • Product descriptionRisedronate sodium ≥97% (HPLC)
  • Packaging50MG
  • Price₹13726.1
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) SML0650 Risedronate sodium ≥97% (HPLC) 50MG ₹13726.1 2022-06-14 Buy

Properties

Melting point :252-262°C
storage temp. :room temp
solubility :H2O: soluble5mg/mL, clear (warmed)
form :powder
color :white to beige
Water Solubility :Soluble to 10 mM in water
BCS Class :3
Stability :Hygroscopic
CAS DataBase Reference :115436-72-1(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P264 Wash hands thoroughly after handling.
P264 Wash skin thouroughly after handling.
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312 IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

Description

Risedronate sodium is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism.
Risedronate sodium is used for the treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures, treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures, treatment of osteoporosis in men at high risk of fractures, and treatment of Paget’s disease. It is marketed as Actonel (tablet) and Atelvia (delayed-release tablet).

Related product price